Supernus Pharmaceuticals, Inc.股价上涨13.67% 市值涨2.39亿美元

自选股智能写手08-07

北京时间2024年08月07日21时31分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价快速拉升13.67%。截至发稿，该股报31.69美元/股，成交量1.0197万股，换手率0.02%，振幅6.38%。最近的财报数据显示，该股实现营业收入1.44亿美元，净利润124000.00美元，每股收益0.00美元，毛利1.07亿美元，市盈率352.11倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2457844800?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-07 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2457844800","market":"us","top_or_hot":-1,"title":"Supernus Pharmaceuticals, Inc.股价上涨13.67% 市值涨2.39亿美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月07日21时31分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价快速拉升13.67%。截至发稿，该股报31.69美元/股，成交量1.0197万股，换手率0.02%，振幅6.38%。最近的财报数据显示，该股实现营业收入1.44亿美元，净利润124000.00美元，每股收益0.00美元，毛利1.07亿美元，市盈率352.11倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131469f17744d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Supernus Pharmaceuticals, Inc.股价上涨13.67% 市值涨2.39亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSupernus Pharmaceuticals, Inc.股价上涨13.67% 市值涨2.39亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-07 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131469f17744d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月07日21时31分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价快速拉升13.67%。截至发稿，该股报31.69美元/股，成交量1.0197万股，换手率0.02%，振幅6.38%。最近的财报数据显示，该股实现营业收入1.44亿美元，净利润124000.00美元，每股收益0.00美元，毛利1.07亿美元，市盈率352.11倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131469f17744d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131469f17744d&s=b","article_id":"2457844800","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131469f17744d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2457844800","pubTimestamp":1723037505,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月07日21时31分，Supernus Pharmaceuticals, Inc.股票出现异动，股价快速拉升13.67%。Supernus Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.98%。其相关个股中，Petiq, Inc.、Supernus Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.涨幅较大，Petiq, Inc.、Sunshine Biopharma Inc.、苏轩堂较为活跃，换手率分别为3.93%、1.23%、1.21%，振幅较大的相关个股有脑再生科技、Supernus Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.，振幅分别为7.97%、6.38%、5.14%。Supernus Pharmaceuticals, Inc.公司简介：Supernus Pharmaceuticals Inc 是一家专业制药公司，致力于开发和商业化治疗包括神经和精神疾病在内的中枢神经系统疾病的产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","SUPN":"Supernus Pharmaceuticals"},"translate_title":"Supernus Pharmaceuticals, Inc. Stock Rises 13.67%, Market Cap Rises $239 Million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SUPN":1},"content_text":"北京时间2024年08月07日21时31分，Supernus Pharmaceuticals, Inc.（SUPN.us）股票出现异动，股价快速拉升13.67%。截至发稿，该股报31.69美元/股，成交量1.0197万股，换手率0.02%，振幅6.38%。最近的财报数据显示，该股实现营业收入1.44亿美元，净利润124000.00美元，每股收益0.00美元，毛利1.07亿美元，市盈率352.11倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Supernus Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.98%。其相关个股中，Petiq, Inc.、Supernus Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.涨幅较大，Petiq, Inc.、Sunshine Biopharma Inc.、苏轩堂较为活跃，换手率分别为3.93%、1.23%、1.21%，振幅较大的相关个股有脑再生科技、Supernus Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.，振幅分别为7.97%、6.38%、5.14%。Supernus Pharmaceuticals, Inc.公司简介：Supernus Pharmaceuticals Inc 是一家专业制药公司，致力于开发和商业化治疗包括神经和精神疾病在内的中枢神经系统疾病的产品。 该公司多样化的神经科学产品组合包括癫痫、偏头痛、注意力缺陷多动障碍(ADHD)、帕金森病(PD)的运动障碍、宫颈肌张力障碍、慢性唾液分泌、PD患者接受左旋多巴治疗的运动障碍，以及成人患者药物诱导的锥体外系反应。公司产品包括 Trokendi XR、Oxtellar XR、Qelbree、APOKYN、XADAGO、MYOBLOC、GOCOVRI 和 Osmolex ER。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2457844800"}